Agenda for March 2026 Cancer Treatments advisory committee (CTAC) meeting
Source: PHARMAC Information on what the Cancer Treatments Advisory Committee (CTAC) will be considering at its upcoming meeting in March 2026. Applications Pertuzumab and trastuzumab for breast cancer Adjuvant treatment for early breast cancer The Committee will discuss an application for pertuzumab and trastuzumab to treat people with HER2-positive early breast cancer at high risk … Read more